Skip to main content
Silas Holland

Silas Holland

Member since August 2023
Executive Director, Global Infectious Disease Policy, Merck

Silas Holland leads global public policy initiatives and advocacy to support Merck’s broad infectious disease portfolio, including HIV treatment and prevention medicines, COVID-19 therapeutics, pandemic preparedness, antibiotics/antifungals and neglected tropical diseases, such as malaria and TB. He was previously the Director of Oncology Policy for Latin America, where he launched major regional projects to facilitate greater access to immuno-oncology treatments. Before joining Merck in 2016, Silas worked at multilateral organizations and NGOs around the world to expand access to medicines, including the World Health Organization, the Global Fund to Fight AIDS, TB and Malaria, UNICEF and Ayuda al Planeta – Guatemala. Silas has a BA in biology from Duke University and postgraduate degrees in education (Loyola Marymount University) and public health (University of Pretoria).

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.